Management of Respiratory Failure in Severe Community-Acquired Pneumonia

  • R. Phillip Dellinger
Part of the Perspectives on Critical Care Infectious Diseases book series (CCID, volume 3)


Most deaths due to community-acquired pneumonia (CAP) are associated with respiratory failure. Patients with respiratory failure are admitted to and managed in an intensive care unit (ICU). Although some patients die directly from hypoxemic respiratory failure or early treatment complications, most die either from complications associated with prolonged mechanical ventilation or severe sepsis/septic shock associated with the primary pneumonia itself. Regardless, the great majority of patients admitted to the intensive care unit with severe community-acquired pneumonia require management of acute respiratory failure.


Acute Respiratory Distress Syndrome Acute Respiratory Failure Respir Crit Adult Respiratory Distress Syndrome Acute Respiratory Distress Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Torres A. Serra-Battles J, Ferrer A. Jimenez P, Celis R. Cobo E, Rodriguez-Roisin R. Severe community-acquired pneumonia. Am Rev Respir Dis 1991; 144:312–318.PubMedCrossRefGoogle Scholar
  2. 2.
    The British Thoracic Society Research Committee and The Public Health Laboratory Service. The etiology. management and outcome of severe community-acquired pneumonia on the intensive care unit. Respiratory Medicine 1992; 86: -13.Google Scholar
  3. 3.
    Leroy O. Santre C. Beuscart C. Georges H, Guery B. Jacquier JM, Beaucaire G. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995; 21:24–31.PubMedCrossRefGoogle Scholar
  4. 4.
    American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity. and initial antimicrobial therapy. Am. Rev. Respir. Dis 1993; 148:1418–1426.Google Scholar
  5. 5.
    Ewig S. Ruiz M. Mensa J. Marcos MA, Martinez JA, Arancibia F. Niederman MS. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 1998; 158:1102–1108.Google Scholar
  6. 6.
    Antonelli M. Conti G. Rocco M. Bull M. De Blasi RA. Vivino G. Gasparetto A, Meduri GU. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998; 339:429–435.PubMedCrossRefGoogle Scholar
  7. 7.
    Hillberg RE, Johnson DC. Noninvasive Ventilation. N Engl J Med 1997; 337:17461752.Google Scholar
  8. 8.
    Hotchkiss JR, Marini JJ. Noninvasive Ventilation: An emerging supportive technique for the emergency department. Ann Emerg Med 1998; 32: 470–479.PubMedCrossRefGoogle Scholar
  9. 9.
    Kramer N. Meyer TJ. Meharg J. Cece RD. Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995: 151: 1799–1806.PubMedGoogle Scholar
  10. 10.
    Meduri GU. Turner RE, Abou-Shala N. Wunderink R, Tolley E. Noninvasive positive pressure ventilation via face: First line intervention in patients with acute hypercapnic and hypoxemic respiratory failure. Chest 1996; 109:179–193.PubMedCrossRefGoogle Scholar
  11. 11.
    Knaus WA. Sun X. Hakim RB. Wagner DP. Evaluation of definitions for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150:311–3 17.Google Scholar
  12. 12.
    Dellinger RP. Acute hypoxemic respiratory failure: acute respiratory distress syndrome as the Prototype. In: ACCP Pulmonary Board Review 1998. Northbrook. Illinois: American College of Chest Physicians. 1998:334–343.Google Scholar
  13. 13.
    Papazian L. Thomas P, Bregeon F. Garbe L. Zandotti C. Saux P, Gaillat F. Drancourt M, Auffray J-P. Gouin F. Open-lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 1998; 88:935–944.PubMedCrossRefGoogle Scholar
  14. 14.
    Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990; 97:1176–1180.PubMedCrossRefGoogle Scholar
  15. 15.
    Monton C. Torres A. Lung inflammatory response in pneumonia Monaldi Archives for Chest Disease 1998; 53:56–63.Google Scholar
  16. 16.
    Ward PA. Recruitment of inflammatory cells into lung: Roles of cytokines. adhesion molecules, and complement. J Lab Clin Med 1997; 129:400–404.PubMedCrossRefGoogle Scholar
  17. 17.
    Fujishima S. Aikawa N. Neutrophil-mediated tissue injury and its modulation. Intensive Care Med 1995; 21:277–285.PubMedCrossRefGoogle Scholar
  18. 18.
    Anzueto A. Baughman RP. Guntupalli KK. Weg JG. Wiedemann HP. Raventos AA, Lemaire F. Long W. Zaccardelli DS. Pattishall EN. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996; 334:1417–1421.Google Scholar
  19. 19.
    Arnold J. Surfactant replacement in acute lung injury-the saga continues. Crit Care Med 1999: 27:31–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Jepsen S, Herlevsen P, Knudsen P, Bud MI Klausen NO. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study. Crit Care Med 1992; 20:918–923.PubMedCrossRefGoogle Scholar
  21. 21.
    Bernard GR, Wheeler AP. Russell JA. Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997; 336:912–918.PubMedCrossRefGoogle Scholar
  22. 22.
    Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 1997; 25:1095–1100.PubMedCrossRefGoogle Scholar
  23. 23.
    Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro M.I. Greenman RL. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double blind, placebo-controlled trial. Phase III rhIL-Ira Sepsis Syndrome Study Group. JAMA 1994; 271:1836–1843.PubMedCrossRefGoogle Scholar
  24. 24.
    Dhainaut JA, Tenaillon A, LeTulzo Y, Schlemmer B, Solet JP. Wolff M, Holzapfel L, Zeni F. Dreyfuss D. Mira JP. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double blind, placebo-controlled, multicenter clinical trial. Crit Care Med 1994; 22:1720–1728.PubMedGoogle Scholar
  25. 25.
    Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Alfred R. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double blind, multicenter clinical trial. TNR-alpha Mab Sepsis Study Group. JAMA 1995; 273:934–941.Google Scholar
  26. 26.
    Cohen J. Carlet J. INTERSEPT: An international. multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 1996; 24:1431–1440.PubMedCrossRefGoogle Scholar
  27. 27.
    Dellinger RP. Inhaled Nitric Oxide in Cardiopulmonary Disease. In: Cernaianu AC (ed) Critical Issues in Surgery. In press.Google Scholar
  28. 28.
    Young JD, Brampton WJ, Knighton, Finfer SR. Inhaled nitric oxide in acute respiratory failure in adults. Br J Anaesth 1994; 73:499–502.PubMedCrossRefGoogle Scholar
  29. 29.
    Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23:499–502.PubMedCrossRefGoogle Scholar
  30. 30.
    Rossaint R. Falke, KF, Lopez F, Salma K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399–405.PubMedCrossRefGoogle Scholar
  31. 31.
    Puybasset L. Rouby JJ, Mourgeon E, Stewart TE, Cluzel P, Arthaud M, Poete P, Bodin L, Korinek AM, Viars P. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994a; 20:319–327.CrossRefGoogle Scholar
  32. 32.
    Michael JR, Barton RG, Sallie JR, Mone M, Markewitz BA, Hillier K, Elstad MR, Campbell EJ, Troyer BE, Whatley RE, Liou TG, Sameulson WM, Carveth HJ, Hinson DM, Morris SE, Davis BL, Day RW. Inhaled nitric oxide versus conventional therapy: Effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998;157:1372–1380.PubMedGoogle Scholar
  33. 33.
    Dellinger, RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL. Criner GJ, Davis K Jr., Hyers TM. Papadakos. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Crit Care Med 1998; 26:15–23.PubMedCrossRefGoogle Scholar
  34. 34.
    Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C for the European Study Group of Inhaled Nitric Oxide. Inhalation of nitric oxide in acute lung injury: Preliminary results of a European multicenter study. Intensive Care Med 1997; 23(suppl. 1):S2.Google Scholar
  35. 35.
    Groupe d’Etude sur le NO inhale’ au course le l’ARDS (GENOA). Inhaled NO ARDS: Presentation of a double blind randomized multicentric study (abstract). Am J Respir Crit Care Med 1996; 153:A590.Google Scholar
  36. 36.
    Marini JJ. Ventilation of the acute respiratory distress syndrome: looking for Mr. Goodmode (editorial). Anesthesiology 1994; 80:972–974.PubMedCrossRefGoogle Scholar
  37. 37.
    Manning HL. Peak airway pressure: Why the fuss? Chest 1994; 105:242–247.PubMedCrossRefGoogle Scholar
  38. 38.
    Desai SR, Hansell DM. Lung imaging in the adult respiratory distress syndrome: Current practice and new insights. Intensive Care Med 1997; 23:7–15.PubMedCrossRefGoogle Scholar
  39. 39.
    Marini JJ. Tidal volume, PEEP and barotrauma: an open and shut case (editorial)? Chest 1996;109:302–304.PubMedCrossRefGoogle Scholar
  40. 40.
    Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150:870–874.PubMedGoogle Scholar
  41. 41.
    Balk R. Permissive hypercapnia: An alternative ventilatory mode for the management of acute lung injury and acute airflow obstruction. Clin Pulm Med 1997; 4:29–33.CrossRefGoogle Scholar
  42. 42.
    Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, Mazer CD, Mclean RF. Rogovein TS, Schouten BD, Todd TR, Slutsky AS. Evaluation of a ventilatory strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Eng1 J Med 1998;338:355–61.CrossRefGoogle Scholar
  43. 43.
    Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R. Takagaki TY, Carvalho CR. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347–354.PubMedCrossRefGoogle Scholar
  44. 44.
    Armstrong, BW, Maclntyre, NR. Pressure-controlled, inverse ratio ventilation that avoids air trapping in the adult respiratory distress syndrome. Crit Care Med 1995; 23:279–285.PubMedCrossRefGoogle Scholar
  45. 45.
    Rappaport SII, Shipner R, Yoshihara G, Wright J, Chang P, Abraham E. Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med 1994;22:22–32.PubMedGoogle Scholar
  46. 46.
    Tharratt RS, Allen RP, Albertson TE. Pressure controlled inverse ratio ventilation in severe adult respiratory failure. Chest 1988; 94:755–762.PubMedCrossRefGoogle Scholar
  47. 47.
    Marini JJ. Down side up-a prone and partial liquid asset. Intensive Care Med 1995; 21:963–965.PubMedCrossRefGoogle Scholar
  48. 48.
    Pappert D. Rossaint R, Slama K, Gruning T, Falke KJ. Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome. Chest 1994: 106:1511–1516.PubMedCrossRefGoogle Scholar
  49. 49.
    Pelosi P, Tubiolo D, Mascheroni D, Vicardi P, Crotti S, Valenza F, Gattinoni L. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. Am J Respir Crit Care Med 1998; 157:387–393.PubMedGoogle Scholar
  50. 50.
    Peterson GW, Baier H. Incidence of pulmonary barotrauma in a medical ICU. Crit Care Med 1983; 11:67–69.CrossRefGoogle Scholar
  51. 51.
    Litmanovitch M, Joynt GM, Cooper PJ, Kraus P. Persistent broncholpleura fistula in a patient with adult respiratory distress syndrome. Treatment with pressure-controlled ventilation. Chest 1993; 104:1901–1902.PubMedCrossRefGoogle Scholar
  52. 52.
    Pierson DJ. Barotrauma and Bronchopleural Fistula. In: Principles and Practice of Mechanical Ventilation. Tobin MJ (ed). New York; McGraw Hill, Inc., 1994: 813–836.Google Scholar
  53. 53.
    Puskas JD, Mathisen DJ, Grillo HC, Wain JC, Wright CD, Moncure AC. Treatment strategies for bronchopleural fistula. J Thorac Cardiovasc Surg 1995; 109:989–996.PubMedCrossRefGoogle Scholar
  54. 54.
    Chaddouk EG. Bronchopleural fistula and mechanical ventilation: A simple technique of management. J Thorac Cardiovasc Surg 1995; 110:1141–1143.PubMedCrossRefGoogle Scholar
  55. 55.
    Baumann MN, Sahn SA. Medical management and therapy of bronchopleural fistulas in the mechanically ventilated patient. Chest 1990; 97:721–728.PubMedCrossRefGoogle Scholar
  56. 56.
    Light RW. Parapneumonic effusions and empyema. Clinics in Chest Med 1985;6:5562.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • R. Phillip Dellinger
    • 1
  1. 1.Rush Medical CollegeRush-Presbyterian-St. Lukes Medical CenterChicagoUSA

Personalised recommendations